Conclusion
In conclusion, low doses of exogenous rhGH, when administered in a manner similar to clinical practice, are associated with glomerular enlargement and stimulation of hypertrophy and hyperplasia of remnant kidneys from uraemic rats. Increased GV was also seen after short term, high dose rhGH therapy in our previous study.[4] The time interval required before increased GV develops with low dose rhGH therapy and whether or not further rhGH exposure subsequently leads to worsening glomerular hypertrophy, glomerulosclerosis[7] and renal failure cannot be determined from the current study. Although we observed no significant changes in renal function with rhGH therapy, we recommend that children with CRI be carefully monitored to ensure that long term rhGH treatment has no such deleterious effects.
References
Arnold WC, Danford D, Holliday M. Effects of caloric supplementation on growth in children with uremia. Kidney Int 1983; 24: 205–9
Mehls O, Ritz E. Skeletal growth in experimental uremia. Kidney Int 1983; 24: S53–S62
Fine R, Kohaut EC, Brown D, et al. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. J Pediatr 1994; 124: 374–82
Arnold WC, Shirkey B, Frindik P, et al. Effect of growth hormone on kidney growth and glomerular structure. Pediatr Nephrol 1991; 5: 529–32
Tonshoff B, Schaefer F, Mehls O. Disturbance of growth hormone-insulin like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment. Pediatr Nephrol 1990; 4: 654–62
Allen DB, Fogo A, El-Hayek R, et al. Effects of prolonged growth hormone administration in rats with chronic renal insufficiency. Pediatr Res 1992; 31: 406–10
Doi T, Striker LJ, Quaife C, et al. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-I. Am J Pathol 1988; 131: 398–403
Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980; 102: 344–52
Hirose K, Osterby R, Nozawa M, et al. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 1982; 21: 689–95
Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, Georgia, USA: 1994
Powell DR, Rosenfeld RG, Hintz RL. Effects of growth hormone therapy and malnutrition on the growth in rats with renal failure. Pediatr Nephrol 1988; 2: 424–30
Santos F, Chan JCM, Hanna JD, et al. The effect of growth hormone on the growth failure of chronic renal failure. Pediatr Nephrol 1992; 6: 262–6
Nakano M, Kainer G, Foreman J, et al. The effects of exogenous rat growth hormone therapy on growth of uremic rats fed an 8% protein diet. Pediatr Res 1989; 26: 204–7
Mehls O, Irzynjec T, Ritz E, et al. Effects of rhGH and rhIGF-I on renal growth and morphology. Kidney Int 1993; 44: 1251–8
Stred SE, Benedict MR, Kuehnling E, et al. Effect of growth hormone on growth and glucose tolerance of normal rats. Am J Dis Child 1987; 141: 502–5
Fine LG, Kurtz I, Woolf AS, et al. Pathophysiology and nephron adaptation in chronic renal failure. In: RW Schrier, CW Gottschalk, editors. Diseases of the kidney, 5th ed. Boston: Little, Brown and Co., 1993: 2703–41
Hirschberg R, Kopple JD. The growth hormone-insulin-like growth factor I axis and renal glomerular function. J Am Soc Nephrol 1992; 2: 1417–22
Frindik JP, Kemp SF, Kearns GL. Epidermal growth factor concentrations in growth hormone deficient children. Effects of single versus multiple injections of recombinant human growth hormone. Drug Invest 1994; 8(5): 257–62
Orlowski CC, Chernausek SD. Discordance of serum and tissue somatomedin levels in growth hormone-stimulated growth in the rat. Endocrinology 1988; 123: 44–9
Olsen S, Paulsen PS, Kirkegaard P, et al. Renal origin of urinary epithelial growth factor in the rat. Regul Pept 1984; 10: 37–47
Perheentupa J, Lakshmanan J, Macaso T, et al. Growth hormone increases neonatal mouse urine epidermal growth factor. Acta Endocrinol 1984; 106: 184–7
Ellis EN, Kemp SF, Frindik JP, et al. Glomerulopathy in patient with Donohue syndrome (Leprechaunism). Diabetes Care 1991; 14(5): 413–4
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frindik, J.P., Arnold, W.C. & Ellis, E. Chronic Low Dose Growth Hormone Treatment Stimulates Both Hypertrophy and Hyperplasia of Remnant Kidneys in Uraemic Rats. Clin. Drug Invest. 10, 183–187 (1995). https://doi.org/10.2165/00044011-199510030-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-199510030-00008